DM2 Therapy and Cardiorenal Outcomes

This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter “real time” you can review the course material here and earn the same credit. 2) First, a poll: SGLT-2 inhibitors were...